Home » Topics » BioWorld Science

BioWorld Science
RSS

Curis and Aurigene amend their collaboration agreement for CA-170

Feb. 7, 2020

HEXAPharmatec discovers new catechol derivatives

Feb. 7, 2020

Cav3.2 blockers patented by Nippon Chemiphar and Kindai University

Feb. 7, 2020

Janssen Biotech describes new STING agonists

Feb. 7, 2020

AVETUX trial shows potential of avelumab and cetuximab with FOLFOX in colorectal cancer

Feb. 7, 2020

Tau keeps gliomas in check

Feb. 7, 2020

Atreca and Merck & Co. collaborate to identify antibody targets in oncology

Feb. 6, 2020

Arthrosi begins phase IIa study of AR-882 for gout

Feb. 6, 2020

BiondVax reports preliminary phase II data on M-001 universal influenza vaccine candidate

Feb. 6, 2020

Antitumor activity seen with pembrolizumab in advanced anal squamous cell carcinoma trial

Feb. 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026